Company / AR per Share
Kymera Therapeutics, Inc. AR per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
-
FY2024
5-year range
$0.00 / $0.31
FY2022-FY2024
Trend
-100.0%
vs FY2023
Sector context
#115 of 115
Health Care
What the data says
Remained stable around $0.00 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 115
▼
Key checks
Key Insights
- In FY2024, ar per share decreased 100.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.31 | - |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 30, 2026